Base de dados : HANSEN
Pesquisa : ANTIVIRAIS [Descritor de assunto]
Referências encontradas : 3 [refinar]
Mostrando: 1 .. 3   no formato [Detalhado]

página 1 de 1

  1 / 3 HANSEN  
              next record last record
seleciona
para imprimir
Id:18947
Autor:Dredge, Keith; Marriott, J. Blake; Dalgleish, Angus G
Título:Immunological effects of thalidomide and its chemical and functional analogs
..-
Fonte:s.l; s.n; 2002. 13 p. ilus, tab.
Resumo:Thalidomide has recently shown considerable promise in the treatment of a number of conditions, such as leprosy and cancer. Its effectiveness in the clinic has been ascribed to wide-ranging properties, including anti-TNF-alpha, T-cell costimulatory and antiangiogenic activity. Novel compounds with improved immunomodulatory activity and side effect profiles are also being evaluated. These include selective cytokine inhibitory drugs (SelCIDs), with greatly improved TNF-alpha inhibitory activity, and immunomodulatory drugs (IMiDs) that are structural analogs of thalidomide, with improved properties. A third group recently identified within the SelCID group, with phosphodiesterase type 4-independent activity, is in the process of being characterized in laboratory studies. This review describes the emerging immunological properties of thalidomide, from a historical context to present-day clinical applications, most notably in multiple myeloma but also in other cancers, inflammatory disease, and HIV. We also describe the laboratory studies that have led to the characterization and development of SelCIDs and IMiDs into potentially clinically relevant drugs. Early trial data suggest that these novel immunomodulatory compounds may supercede thalidomide to become established therapies, particularly in certain cancers. Further evidence is required, however, to correlate the clinical efficacy of these compounds with their known immunomodulatory, antiangiogenic, and antitumor properties. (AU).
Descritores:TALIDOMIDA/analog
TALIDOMIDA/imunol
TALIDOMIDA/farmacol
SISTEMA IMUNE/ef drogas
NEOPLASIAS/quimioter
NEOPLASIAS/imunol
INFECCOES POR HIV/quimioter
INFECCOES POR HIV/imunol
ADJUVANTES IMUNOLOGICOS/farmacol
INIBIDORES DE ANGIOGÊNESE/imunol
INIBIDORES DE ANGIOGÊNESE/farmacol
ANTIVIRAIS/imunol
ANTIVIRAIS/farmacol
Limites:HUMANO
Meio Eletrônico: - .
Localização:BR191.1; 04731/s


  2 / 3 HANSEN  
              first record previous record next record last record
seleciona
para imprimir
Id:14319
Autor:Creange, Alain
Título:Neuropathies infectieuses
..-
Fonte:s.l; s.n; 2000. 6 p. tab.
Descritores:ANTIVIRAIS
INFECÇOES POR HIV
HEPATITE C
HOSPEDEIRO IMUNOCOMPROMETIDO
HANSENIASE
DOENÇA DE LYME
DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
DOENÇAS DO SISTEMA NERVOSO PERIFÉRICO
Localização:BR191.1; 07387/s


  3 / 3 HANSEN  
              first record previous record
seleciona
para imprimir
Id:5684
Autor:David, Hugo L; Clavel, Sabine; Clement, Françoise; Moniz-Pereira, José
Título:Effects of antituberculosis and antileprosy drugs on mycobacteriophage D29 growth
..-
Fonte:s.l; s.n; 1980. 2 p. graf, tab.
Descritores:MYCOBACTERIUM
ANTITUBERCULOSOS
ANTIVIRAIS
LEPROSTATICOS
TESTES DE SENSIBILIDADE MICROBIANA
MICOBACTERIOFAGOS
MICOBACTERIOFAGOS
Localização:BR191.1; 02649/s



página 1 de 1
   


Refinar a pesquisa
  Base de dados : HANSEN Formulário avançado   
Pesquisar por : Formulário livre   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6.1 powered by WWWISIS

BIREME/PAHO/WHO - Latin American and Caribbean Center on Health Sciences Information